You are here: Home - RenDx® RUO Multiplex assay system (in development) - Invasive fungal infection

Invasive fungal infection

Page contentDownloads  Contact us

Overview

RenDx RUO KitboxInvasive fungal infections (IFIs) have emerged as a growing threat to human health. In particular, medical advances in the management of cancer patients and hematpoietic stem cell and organ transplantation, in addition to imune compromising conditions such as AIDS, have created a population at risk from invasive fungal disease.

The RenDx Fungiplex panel will allow the detection of the causative agents of IFI for clinical research. The assay covers the most commonly occuring pathogens as well as some of the genera or species that, although they occur rarely, are still considered to be significant human pathogens. The assay detects nucleic acid extracted directly from samples of whole blood, plasma or serum, using standard DNA extraction methods.

Targets

Candida         Aspergillus       
Candida spp.*Aspergillus spp.*
          C. albicans          A. fumigatis
          C. parasilosis          A. glaucus
          C. tropicalis          A. flavus
          C. viswanthii          A. terreus
          C. guilliermondii          A. niger
          C. inconspicua          A. ustus
          C. lusitaniae          A. candidus
          C. dubliniensis          A. versicolor
          C. kefyr 
          C. famata 
C. krusei* 
C. glabrata* 

* reported

FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC PURPOSES. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Next steps

Contact us online if you require more information or you have a pricing query, or alternatively you may like to speak directly to Renishaw Diagnostics.